AIM: False STEMI activations lead to costs, inappropriate cath lab use

 
 
 

after activation, activation protocol violation, and morbid conditions with ECG changes mimicking myocardial infarction for which a coronary angiogram would be contraindicated,” Bachour and Asinger wrote.

The editorialists noted that this inappropriate activation could increase costs and expose patients to risk. Due to disparities highlighted in the literature, the editorialists said that measures must be established to ensure quality of reperfusion programs, particularly to help stamp out false-positive activations.

“The quality of acute reperfusion therapy should be judged not only on the basis of door-to-treatment time but also the ratio of 'appropriate' vs. 'inappropriate' activation of reperfusion therapy,” Bachour and Asinger summed.